XML 65 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Accrued Expenses and Other Liabilities (Tables)
12 Months Ended
Dec. 31, 2021
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of Accrued Expenses and Other Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
As at December 31
 
    
2020
    
2021
    
2021
 
    
RMB
    
RMB
    
US$
 
Current portion:
                          
Customer advances*
     191,357        378,957        59,467  
Salary and welfare payable
     117,506        600,775        94,275  
Purchase of property and equipment
     181,038        759,391        119,165  
Accrued expenses
     44,559        116,021        18,206  
Other tax and surcharges payable
     25,227        91,287        14,325  
Deferred government grants
     10,321        8,488        1,332  
Purchase consideration payable**
     —          148,038        23,230  
Individual income tax payable*** (Note 7)
     231,377        48,949        7,681  
Others****
     43,989        71,934        11,288  
    
 
 
    
 
 
    
 
 
 
       845,374        2,223,840        348,969  
    
 
 
    
 
 
    
 
 
 
Non-current
portion:
                          
Deferred government grants
     7,020        6,975        1,095  
Purchase consideration payable**
     —          1,180,470        185,242  
Others****
     33,558        45,232        7,097  
    
 
 
    
 
 
    
 
 
 
       40,578        1,232,677        193,434  
    
 
 
    
 
 
    
 
 
 
*
The amount represents contract liabilities for
the
rendering of services. The increase in customer advances as compared to December 31, 2020 is a result of the increase in consideration received from the Group’s customers.
**
The amount represents
the
remaining
purchase consideration to acquire Camelot. RMB148,038 (US$23,230) will be settled by April 30, 2022 and RMB1,180,470 (US$185,242) will be settled by June 30, 2023
. A total of
 RMB921,496 (US$144,603) will be settled by
 
the Company’s 
ordinary shares.
***
Represents IIT payable to the tax bureau on behalf of certain employees related to their exercise and vesting of share-based awards.
****
In July 2020, the Company received a reimbursement of US$7,469 (equivalent to RMB47,597) from the depository for the establishment and maintenance of the ADS program (“ADS Reimbursement”). As of December 31, 2020 and 2021, RMB10,083 and RMB9,836 (US$1,543) were included in the current portion, and RMB33,558 and RMB22,989 (US$3,607) were included in the
non-current
portion of accrued expenses and other liabilities, respectively. The ADS Reimbursement will be released to the consolidated statements of comprehensive loss in equal amounts over the ADS program term.